SI2298766T1 - Farmacevtske formulacije, ki vsebujejo substituiran derivat piridina - Google Patents

Farmacevtske formulacije, ki vsebujejo substituiran derivat piridina

Info

Publication number
SI2298766T1
SI2298766T1 SI200631682T SI200631682T SI2298766T1 SI 2298766 T1 SI2298766 T1 SI 2298766T1 SI 200631682 T SI200631682 T SI 200631682T SI 200631682 T SI200631682 T SI 200631682T SI 2298766 T1 SI2298766 T1 SI 2298766T1
Authority
SI
Slovenia
Prior art keywords
comrpising
pharmaceutical formulations
pyridine derivative
substituted pyridine
derivative
Prior art date
Application number
SI200631682T
Other languages
English (en)
Inventor
Christian Wenzel Tornoe
Nikolay Khanzhin
Mario Rottlander
William Patrick Watson
Daniel Rodriguez Greve
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Priority claimed from EP10182072.8A external-priority patent/EP2298766B1/en
Publication of SI2298766T1 publication Critical patent/SI2298766T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200631682T 2005-03-03 2006-03-02 Farmacevtske formulacije, ki vsebujejo substituiran derivat piridina SI2298766T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65842805P 2005-03-03 2005-03-03
DKPA200500321 2005-03-03
EP10182072.8A EP2298766B1 (en) 2005-03-03 2006-03-02 Pharmaceutical formulations comrpising a substituted pyridine derivative

Publications (1)

Publication Number Publication Date
SI2298766T1 true SI2298766T1 (sl) 2014-05-30

Family

ID=37908541

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631682T SI2298766T1 (sl) 2005-03-03 2006-03-02 Farmacevtske formulacije, ki vsebujejo substituiran derivat piridina

Country Status (14)

Country Link
KR (2) KR20070108884A (sl)
CN (3) CN102516165A (sl)
AR (1) AR052931A1 (sl)
BR (1) BRPI0608122A2 (sl)
DK (1) DK2298766T3 (sl)
EA (1) EA016244B1 (sl)
ES (1) ES2433593T3 (sl)
HK (1) HK1164868A1 (sl)
IL (1) IL185113A (sl)
NZ (1) NZ556613A (sl)
PT (1) PT2298766E (sl)
SI (1) SI2298766T1 (sl)
UA (1) UA92340C2 (sl)
ZA (1) ZA200705987B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114409593B (zh) * 2022-01-20 2024-02-23 上海泾维化工科技有限公司 一种2-氨基-5-甲基吡啶的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60037321T4 (de) * 1999-08-04 2010-01-07 Icagen, Inc. Benzanilide als öffner des kaliumkanals
MXPA03000032A (es) * 2000-06-29 2003-08-19 Neurosearch As Uso de derivados de oxindol 3-sustituidos como moduladores de los canales de potasio kcnq.
HUP0303841A2 (hu) * 2001-02-20 2004-03-01 Bristol-Myers Squibb Company 2,4-Diszubsztituált-5-pirimidinkarboxamid-származékok mint KCNQ káliumcsatorna modulátorok és ezeket tartalmazó gyógyszerkészítmények és előállításuk
MXPA05010000A (es) * 2003-03-21 2005-11-17 Lundbeck & Co As H Derivados de p-diaminobenceno substituidos.
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives

Also Published As

Publication number Publication date
EA200701877A1 (ru) 2008-02-28
UA92340C2 (en) 2010-10-25
CN102276523B (zh) 2014-12-10
AR052931A1 (es) 2007-04-11
DK2298766T3 (da) 2013-11-11
ZA200705987B (en) 2009-05-27
ES2433593T3 (es) 2013-12-11
CN102276523A (zh) 2011-12-14
IL185113A0 (en) 2007-12-03
BRPI0608122A2 (pt) 2010-11-09
EA016244B1 (ru) 2012-03-30
KR20070108884A (ko) 2007-11-13
NZ556613A (en) 2010-11-26
PT2298766E (pt) 2013-11-07
HK1164868A1 (en) 2012-09-28
CN101133053A (zh) 2008-02-27
KR20130088905A (ko) 2013-08-08
CN102516165A (zh) 2012-06-27
IL185113A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
PL2298766T3 (pl) Preparaty farmaceutyczne zawierające podstawione pochodne pirydyny
IL186521A0 (en) Nanoparticle-active ingredient conjugates
LT1912671T (lt) Vaisto konjugatai, turintys gliukoronido linkerį
EP1741703A4 (en) PYRIDONE DERIVATIVE
ZA200703912B (en) 3-arylamino pyridine derivatives
AP2007003887A0 (en) Pyridine derivatives
HK1203351A1 (en) Pharmaceutical composition comprising a glucopyranosyl substituted benzene derivative
IL191907A0 (en) Azepinoindole derivatives as pharmaceutical agents
IL177566A0 (en) Pharmaceutical formulations
ZA200801162B (en) Trazodone composition for once a day administration
EP1820797A4 (en) SUBSTITUTED PYRIDONE DERIVATIVE
HK1121950A1 (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
GB0426301D0 (en) Pharmaceutical formulations
IL182703A0 (en) Pharmaceutical compositions comprising a camtothecin derivative
EP1718335A4 (en) CONJUGATES OF DRUGS
IL193774A0 (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
EP2025667A4 (en) 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS
IL198160A0 (en) Pharmaceutical formulations
SI2298766T1 (sl) Farmacevtske formulacije, ki vsebujejo substituiran derivat piridina
HK1092734A1 (en) Oral formulation for twice-daily administration
GB0406048D0 (en) Drug formulations
GB0522473D0 (en) A pharmaceutical formulation
EP1864664A4 (en) PHARMACEUTICAL PREPARATION
GB0612556D0 (en) Topical pharmaceutical formulations
ZA200707127B (en) Pyridyl non-aromatic nitrogen-cotaining heterocyclic-1-carboxylate derivative